SCHEMBL25935366

SCHEMBL25935366

COc1cc(N2CCC(CO)CC2)ccc1-c1ccc(C)nc1OCc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.46
SUV39H2 Q9H5I1 2/20 0.43
PDE7A Q13946 1/20 0.43
ALK Q9UM73 1/20 0.40
TLR9 Q9NR96 4/20 0.40
HTR1A P08908 4/20 0.40
HTR1D P28221 4/20 0.40
HTR1B P28222 4/20 0.40
TLR7 Q9NYK1 3/20 0.40
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
ALDH1A1 P00352 1/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
ALOX12 P18054 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
DNMT3A Q9Y6K1 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24670613 0.92 LRRK2 (0.46) LRRK2SUV39H2PDE7AALKTLR9
SCHEMBL30066370 0.92 LRRK2 (0.46) LRRK2SUV39H2PDE7AALKTLR9
SCHEMBL25666759 0.86 LRRK2 (0.44) LRRK2ALKHTR1AHTR1DHTR1B
SCHEMBL25935365 0.85 PDK2 (0.48) KDM4EMEN1ALDH1A1TP53GAA
SCHEMBL25819578 0.85 HTR1A (0.45) LRRK2HTR1AHTR1DHTR1B
SCHEMBL25935357 0.83 ITGB2 (0.39) LRRK2MAPTMAPK1EHMT2
SCHEMBL30066428 0.82 LRRK2 (0.45) LRRK2SUV39H2TLR9HTR1AHTR1D
SCHEMBL24671125 0.82 LRRK2 (0.45) LRRK2SUV39H2TLR9HTR1AHTR1D
SCHEMBL29013164 0.80 ALK (0.43) LRRK2ALKTLR9TLR7KDM4E
SCHEMBL25666797 0.79 MAPT (0.38) LRRK2ALKHTR1AHTR1DHTR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND PLK1, BUB1B, BUB1 LRRK2 96/4885SUV39H2 2510/4885PDE7A 3233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.